Assessment of proton-pump inhibitor use, race, socioeconomic status, and mortality in individuals with COVID-19.

Aby, Elizabeth S; Tappata, Manaswita; Rodin, Holly; Debes, Jose D

Aby, Elizabeth S; Tappata, Manaswita; Rodin, Holly; Debes, Jose D.

Aby ES; Division of Gastroenterology and Hepatology, Hennepin Healthcare.
Tappata M; Department of Medicine, University of Minnesota.
Rodin H; Department of Medicine, University of Minnesota.
Debes JD; Analytic Center of Excellence, Hennepin County Medical Center, Minneapolis, Minnesota, USA.

Eur J Gastroenterol Hepatol ; 34(2): 239, 2022 02 01.

Article in English | MEDLINE | ID: covidwho-1532612

Subject(s)

COVID-19; Proton Pump Inhibitors; Humans; Proton Pump Inhibitors/adverse effects; SARS-CoV-2; Social Class

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Proton Pump Inhibitors / COVID-19 Limits: Humans Language: English Journal: Eur J Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google